Patient Rating:

4.5 out of 5

40 Patient Ratings
14 Patient Comments

Stavros G. Drakos, M.D., Ph.D.

Patient Rating:

4.5 out of 5

40 Patient Ratings
14 Patient Comments

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-3693 University Hospital
Heart Transplant Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map
(801) 585-5122 University Hospital
Heart Failure Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

Stavros G. Drakos, MD/PhD is the Medical Director of the Cardiac Mechanical Support Program, Assistant Professor of Medicine/Cardiology, University of Utah and an Investigator at the Molecular Medicine Program, Eccles Institute of Human Genetics. He received his M.D. degree from the Medical School of the National University of Athens, Greece (1991 - 1997, Summa Cum Laude), and his PhD from the same university (1997-2000/ Mentor J.N.Nanas, ex-trainee of the Univ. of Utah), with a thesis titled, “Pulsatile vs. non-pulsatile cardiac mechanical support in a porcine model of heart failure” (Award "Top 3 PhD Theses 2000-2005", Univ. of Athens). After finishing his internal medicine residency in Athens (1999-2001) he went on to complete an extended clinical and research fellowship in heart failure, transplant, and mechanical circulatory support at the University of Utah/ UTAH Cardiac Transplant program under the mentorship of Drs. Dale Renlund and E.M. Gilbert (2001-2003). He then completed a fellowship in clinical cardiology at the National University of Athens (2003 - 2006). Upon completion of his cardiology fellowship he joined the Division of Cardiology/ Department of Clinical Therapeutics, University of Athens and focused his clinical and research efforts on the advancement of the "Harefield - Athens Cardiac Recovery Program" working closely with Drs. John Nanas/ University of Athens and Sir Magdi Yacoub/ Imperial College London (2004-2007). In 2007 he returned to the University of Utah to complete a post-doctoral in molecular medicine and heart failure at the Molecular Medicine Program, Eccles Institute of Human Genetics (2007 -2008). In 2008, Dr. Drakos was appointed as Assistant Professor of Medicine/ Cardiology and in 2012 he was also appointed as the Medical Director of the Cardiac Mechanical Support Program, University of Utah Healthcare.

His clinical specialties include Heart Failure, Cardiac Mechanical Support, Cardiac Transplantation, CV Intensive Care Unit and General Cardiology. Dr. Drakos sees patients at the Cardiovascular Center, University of Utah Hospital, 50 N Medical Dr, Salt Lake City, Utah, 84132. For appointments please call 801-585-5122.

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.4
My confidence in care provider
4.5
Time care provider spent with me
4.3
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.3
Care provider's concern for questions & worries
4.5
Care provider's explanation of condition/problem
4.5
Wait time at clinic
3.6
Care provider's friendliness and courtesy
4.7

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 07, 2014

Since we were in for a test, no results were available for the doctor or PA to share with us. They had seen us before, and were aware of the conditions, and of our concerns.

June 23, 2014

My previous appointment I was told that my heart may be getting worse and there was talk about ventricular assist or other items. It appears that my heart is the same as it was over the last few years based on the Echo. However, the problem of low BP and low Oxygen levels when active have not been addressed

May 06, 2014

Dr. Drakos' accent is difficult to understand, therefore he needs to speak slowly & distinctly.

February 18, 2014

Dr. Drakos was excellent, I was confident in his care and his attention to my concerns and issues. I agree with the comment that I read from another patient..... it would be beneficial to me to be able to listen to the discussion between the nurse and doctor. It would improve my understanding of my case and increase my peace of mind.

November 13, 2013

I really like Dr. Drakos. He is the only Dr. there who has been willing to think outside the box somewhat. He has been a big help when is comes to the breathing problems I was having. However, no one there has been willing or maybe able to address and figure out why my blood pressure drops so low so often since I had my defibrillator put in. No one seems curious enough to try to find out why. I bring it up at every visit but they don't know what to do about it so they simply tell me not to worry about it. This is frustrating for me! They don't have to live with the problem, I DO! and I'm tired of it. It is frustrating and debilitating in so many ways. If y'all can't figure it out please send me to someone who can, I would so appreciate it!

November 08, 2013

very good

October 22, 2013

all have treated me great

July 09, 2013

Dr. Drakos is really the only doctor in your office who has really taken an interest in the problems and symptoms I have. He's the only doctor who has taken the time to think outside the box and really try to find out what is going on with me. I have felt utterly dismissed by the other doctors in the Cardiology department. Because they couldn't find anything glaringly wrong with my heart they have basically ignored me. Dr. Drakos studied my chart and realized, because of my history, it could be something other than my heart causing my symptoms. Because of his expertise and inquisitiveness I think we might make some progress. At least he makes me feel that I am worth his time and effort and you can't possibly know how much that means to me. The other doctors in your office could take a few lessons from him. THINK OUTSIDE THE BOX!!!!!!

July 08, 2013

We have had an incredible experience with the facility and all staff!

July 01, 2013

from the reception to the doctor,all of them are exeptional!

June 24, 2013

The entire team that saw me was very interested in my symptoms and my case. This is something I have never experienced before. They did not tell me that, "it was all in my head" as many other physicians I have seen regarding these episodes have. They asked very thorough questions regarding my episodes, and wrote everything down. Over the past 6 years, I have never found a team of physicians that have helped me as much as they have.

April 29, 2013

I was treated like. person. with concern and care. I am asked if I understand my condition and explained what I don't. I am explained what is happening to me. I am reassured that I am in good hands. and I feel at ease because I am being talked to and looked at.

April 24, 2013

excellent service

October 29, 2012

This was the first time I met with the doctor, He did apologize for running so late, which was nice.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-0700 George and Dolores Eccles Institute of Human Genetics
Molecular Medicine Program
15 N 2030 E
Salt Lake City, UT 84112
(801) 585-2340 School of Medicine
Division of Cardiovascular Medicine
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Stavros G. Drakos, MD/PhD is the Medical Director of the Cardiac Mechanical Support Program, Assistant Professor of Medicine/Cardiology, University of Utah and an Investigator at the Molecular Medicine Program, Eccles Institute of Human Genetics. He received his M.D. degree from the Medical School of the National University of Athens, Greece (1991 - 1997, Summa Cum Laude), and his PhD from the same university (1997-2000/ Mentor J.N.Nanas, ex-trainee of the Univ. of Utah), with a thesis titled, “Pulsatile vs. non-pulsatile cardiac mechanical support in a porcine model of heart failure” (Award "Top 3 PhD Theses 2000-2005", Univ. of Athens). After finishing his internal medicine residency in Athens (1999-2001) he went on to complete an extended clinical and research fellowship in heart failure, transplant, and mechanical circulatory support at the University of Utah/ UTAH Cardiac Transplant program under the mentorship of Drs. Dale Renlund and E.M. Gilbert (2001-2003). He then completed a fellowship in clinical cardiology at the National University of Athens (2003 - 2006). Upon completion of his cardiology fellowship he joined the Division of Cardiology/ Department of Clinical Therapeutics, University of Athens and focused his clinical and research efforts on the advancement of the "Harefield - Athens Cardiac Recovery Program" working closely with Drs. John Nanas/ University of Athens and Sir Magdi Yacoub/ Imperial College London (2004-2007). In 2007 he returned to the University of Utah to complete a post-doctoral in molecular medicine and heart failure at the Molecular Medicine Program, Eccles Institute of Human Genetics (2007 -2008). In 2008, Dr. Drakos was appointed as Assistant Professor of Medicine/ Cardiology and in 2012 he was also appointed as the Medical Director of the Cardiac Mechanical Support Program, University of Utah Healthcare.

Research Interests

Dr Drakos's research interests are focused on advanced heart failure therapies and mechanical unloading-induced reverse myocardial remodeling and cardiac recovery. During the last several years he has been splitting his time between the UTAH clinical HF/Transplant/Cardiac Mechanical Support program and the Univ. of Utah Molecular Medicine program where his lab is located in an effort to advance a prospective translational research program that investigates the impact of mechanical unloading on the failing human heart. These prospective investigations are combining serial clinical/ functional myocardial evaluations with longitudinal structural/ molecular readouts through a tight collaboration between the basic services at the Molecular Medicine program and the clinical HF/ VAD/ transplant services.

Information about the Annual Utah Cardiac Recovery Symposium (U-CARS): http://medicine.utah.edu/cardiacrecoverysymposium/

Direct Contact Info for Collaborations

Cardiac Mechanical Support Program,

Division of Cardiovascular Medicine,

Molecular Medicine Program/Eccles Institute of Human Genetics,

University of Utah, 30 North 1900 East, Room 4A100 SOM, Salt Lake City, 84132, UT

Email: stavros.drakos@hsc.utah.edu, Office: 801-5852340, Clinic: 801-5855122, Fax: 801-5852319

Research Grants

1). Doris Duke Foundation Research Grant

2). Deseret Foundation IRMF Grant

Completed Research Grants

1). European Union Research Executive Agency (Brussels, Belgium) - FP7 Marie Curie Grant

Title: Unload failing heart

2). American Heart Association

Grant # 09CRP2050127

3). Clinical and Translational Science Award Institutions (CTSA/ NIH) - University of Utah CCTS

Title: Reverse remodeling during mechanical unloading of the left ventricle

4). A. G. Leventis Foundation (Zurich, Switzerland) - Young Investigator Grant- Experimental Cardiology

Title: Pulsatile versus non pulsatile unloading in experimental heart failure.

5). General Secretariat for Research and Technology (EU) - Research in Cardiovascular Medicine: PENED/ 1999

Title: Hemodynamic effects during cardiac mechanical support in an in vitro-mock circulation model.

6). Bodossakis Foundation (Athens, Greece) - Young Investigator Grant- Experimental Cardiology

Title: Pulsatile versus non pulsatile mechanical circulatory support in a porcine model of cardiogenic shock.

Ongoing Clinical Trials

1) Remisision of Stage D Heart Failure - RESTAGE LVAD recovery trial (Thoratec Corporation)

2) Allogeneic Mesenchymal Precursor Cells (CEP–41750) in Patients with Chronic Heart Failure (Teva Pharmaceuticals)

3) Clinical Trials in Transplantation (CTOT) - Prevention of coronary allograft vasculopathy with Rituximab (NIH)

4) Randomized trial of HeartMate II vs Heartware for destination therapy - Endurance trial (HeartWare, Inc)

5) Risk assessment and comparative effectiveness of left ventricular assist device and medical management

in ambulatory heart failure patients - ROADMAP (Thoratec Corporation)

6) Interagency Registry for Mechanically Assisted Circulatory Support - INTERMACS (NIH/ NHLBI NO1-HV-18246)

Education

Education History

Type School Degree
Fellowship University of Athens
General Cardiology Fellowship
Fellow
Fellowship University of Utah & U.T.A.H. Cardiac Transplant Program
Heart Failure/ Transplant/ Mechanical Support Fellowship
Fellow
Doctoral Training University of Athens
Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Summa Cum Laude
Ph.D.
Residency University of Athens
Internal Medicine
Resident
Professional Medical University of Athens
Medicine, Summa Cum Laude
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Frech T, De Domenico I, Murtaugh MA, Revelo MP, Li DY, Sawitzke AD, Drakos SG (2014). Autophagy is a key feature in the pathogenesis of scytemic sclerosis. Rheumatol Int, 34(3), 435-439.
  2. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama ME, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (In press). Myocardial atrophy and metabolic changes during mechanical unloading of the failing human heart: implications for ventricular assist devices-induced cardiac recovery. J Am Coll Cardiol.
  3. Drakos SG, Uriel N (2014). Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support. Curr Opin Cardiol.
  4. Drakos SG (2014). The Odyssey of Chronic Cardiac Mechanical Support. J Am Coll Cardiol, Feb 27.
  5. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
  6. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94.
  7. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Drakos SG (2013). Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol, 62(23), 2257-8.
  8. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  9. Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, Diakos N, Koudoumas D, Theodoropoulos S, Yacoub MH, Anastasiou-Nana MI (2011). Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg, 91(3), 764-9.
  10. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest, 121(5), 1871-81.
  11. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN (2010). Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging, 3(1), 64-70.
  12. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW (2010). Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol, 105(7), 1030-5.
  13. Dimopoulos SK, Drakos SG, Terrovitis JV, Tzanis GS, Nanas SN (2010). Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant, 29(8), 906-8.
  14. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91.
  15. Verma DR, Drakos SG, Stehlik J, Horne BD, Kfoury AG (2010). Effect of preservation solution choice on antibody-mediated rejection after heart transplantation. J Heart Lung Transplant, 29(11), 1314-5.
  16. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li Y, Kfoury AG (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc, 42(7), 2687-92.
  17. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med, 15(2), 177-84.
  18. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN (2009). Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. J Cardiovasc Pharmacol, 53(2), 157-61.
  19. Kanakakis J, Nanas JN, Tsagalou EP, Maroulidis GD, Drakos SG, Ntalianis AS, Tzoumele P, Skoumbourdis E, Charbis P, Rokas S, Anastasiou-Nana M (2009). Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: The Athens PCI trial. Catheter Cardiovasc Interv, 74(3), 398-405.
  20. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas JN (2009). Long-Term Survival and Outcomes After Hospitalization for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Clin Cardiol, 32(8), E4-E8.
  21. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42.
  22. Struber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince P (2008). HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg, 34(2), 289-94.
  23. Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, Drakos SG, Koudoumas D, Charitos CE, Anastasiou-Nana MI (2008). Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. Int J Cardiol.
  24. Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN (2008). Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis? Coron Artery Dis, 19(7), 521-6.
  25. Ntalianis AS, Drakos SG, Charitos C, Dolou P, Pierrakos CN, Terrovitis JV, Papaioannou T, Charitos E, Nanas JN (2008). Effects of intra-aortic balloon pump versus centrifugal pump on myocardial energetics and systemic circulation in a porcine model of rapidly worsening acute heart failure. ASAIO J, 54(6), 600-5.
  26. Drakos SG, Kfoury AG, Gilbert EM, Long JW, Stringham JC, Hammond EH, Jones KW, Bull DA, Hagan ME, Folsom JW, Horne BD, Renlund DG (2007). Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg, 83(1), 62-7.
  27. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, Campbell BA, Renlund DG (2007). Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 26(4), 319-23.
  28. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG (2007). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg, 133(6), 1612-9.
  29. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Horne BD, Hagan MB, Nelson K, Renlund DG (2007). Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure. Eur J Heart Fail, 9(8), 845-9.
  30. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Moore SA, Campbell BK, Nelson KE, Horne BD, Renlund DG (2006). Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant, 25(1), 22-8.
  31. Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006). Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg, 82(3), 889-93.
  32. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006). Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol, 48(12), 2485-9.
  33. Anastasiou-Nana MI, Tsagalou EP, Charitos C, Siafakas KX, Drakos S, Terrovitis JV, Ntalianis A, Doufas A, Mavrikakis J, Nanas JN (2005). Effects of transient myocardial ischemia on the ventricular defibrillation threshold. Pacing Clin Electrophysiol, 28(2), 97-101.
  34. Anastasiou-Nana MI, Tsagalou EP, Mavrikakis EM, Siafakas KX, Tsolakis EJ, Drakos SG, Dalianis A, Karelas J, Terrovitis JV, Nanas JN (2005). Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds. Resuscitation, 64(3), 373-6.
  35. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P, Pierrakos C, Charitos E, Karelas J, Nanas JN (2005). Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO J, 51(1), 26-9.
  36. Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos CE (2004). Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest, 125(4), 1492-9.
  37. Tsagalou EP, Anastasiou-Nana MI, Charitos CE, Siafakas CX, Drakos SG, Ntalianis A, Terrovitis JV, Mavrikakis EM, Doufas A, Nanas JN (2004). Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. Resuscitation, 61(1), 83-9.
  38. Drakos SG, Papamichael CM, Alexopoulos GP, Anastasiou-Nana MI, Stathopoulos JV, Nanas JN (2003). Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol, 91(7), 885-8.

Review

  1. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. [Review]. Pharmacology & Therapeutics, 134(2), 189-99.
  2. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. [Review]. Curr Opin Cardiol, 26(3), 245-55.
  3. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN, Nanas JN (2009). Anemia in heart failure: pathophysiologic insights and treatment options. [Review]. Future Cardiology, 5(1), 71-81.
  4. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN (2009). Anemia in chronic heart failure. [Review]. Congestive Heart Failure, 15(2), 87-92.
  5. Drakos SG, Charitos EI, Nanas SN, Nanas JN (2007). Ventricular-assist devices for the treatment of chronic heart failure. [Review]. Expert Rev Cardiovasc Ther, 5(3), 571-84.
  6. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN (2007). Reverse remodeling during long-term mechanical unloading of the left ventricle. [Review]. J Mol Cell Cardiol, 43(3), 231-42.

Book Chapter

  1. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos SG (2013). Mechanical unloading and heart remodeling features. In Edmo Gabriel, Sthefano Gabriel (Eds.), Inflammatory response in cardiovascular surgery, New York, NY: Springer.
  2. Terrovitis JV, Tseliou E, Drakos SG, Nanas JN (2011). Evaluation of Cardiac Function after VAD Implantation, New Aspects of Ventricular Assist Devices, Guillermo Reyes (Ed.), ISBN: 978-953-307-676-8, InTech, Available from : http://www.intechopen.com/books.
  3. Tsagalou EP, Drakos SG, Tsolakis E, Nanas J (2008). Intra-aortic balloon pump in the management of acute heart failure syndromes. In Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph Parrillo (Eds.), Acute Heart Failure (pp. 671-684). New York, NY: Springer.
  4. Drakos SG, Alexopoulos G, Nanas JN (2005). Organizing a heart failure program. In Filippatos G, Adamopoulos S, Parissis J, Anthopoulos L, Kremastinos D (Eds.), Heart Failure: from diagnosis to treatment (pp. 453-464). Athens, Greece: Paschalides Editions.

Clinical Trials

Clinical Trials

  • CTOT-11
    Keywords: Heart Transplant, Heart Failure, Rituximab, Transplant
    Status: Recruiting Principal Investigator: Josef Stehlik
  • PARAGON
    Keywords: Heart Failure, HFpEF, Structural Heart Disease
    Status: Not yet recruiting Principal Investigator: John Ryan
  • NEAT HFpEF
    Keywords: Heart Failure, Preserved Ejection Fraction, HFpEF, Nitrates, Activity Tolerance
    Status: Not yet recruiting Principal Investigator: Jose Nativi-Nicolau
  • RESTAGE - HF
    Keywords: Heart Failure, LVAD, Left Ventricular Assist Device, Heart Recovery
    Status: Not yet recruiting Principal Investigator: Craig Selzman
  • FIGHT-HF
    Keywords: Heart Failure, Heart, Liraglutide, Victoza
    Status: Recruiting Principal Investigator: Josef Stehlik

Video & News

News

Video